Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Foreign Drug Makers Consider Japanese Market More Important Than Japanese Drug Companies

This article was originally published in PharmAsia News

Executive Summary

According to a recent survey conducted by Booz & Company on the pharmaceutical industry for the next 10 years in Japan, 38 percent of foreign pharmaceutical companies operating in Japan consider the Japanese market very important to them. In contrast, 27 percent of Japanese major pharmaceutical companies and 18 percent of middle sized drug makers share the same view. Among the major Japanese drug makers, 36 percent plans to focus on overseas market. Out of 248 target foreign and Japanese domestic companies, 35 companies answered the survey. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts